WO1996027406A1 - Slowly dilating device for the urethra - Google Patents
Slowly dilating device for the urethra Download PDFInfo
- Publication number
- WO1996027406A1 WO1996027406A1 PCT/IB1996/000143 IB9600143W WO9627406A1 WO 1996027406 A1 WO1996027406 A1 WO 1996027406A1 IB 9600143 W IB9600143 W IB 9600143W WO 9627406 A1 WO9627406 A1 WO 9627406A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pressure responsive
- dilation
- urethra
- meens
- urethre
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
Definitions
- This invention relates generally to dilation devices for the urethra and to the treatment of hypertrophy of the prostate gland. More specifically it relates to novel devices for slowly dilating obstructed portions of the urethra, and to concomitant methods for slowly dilating an obstructed portion of the urethra and for treating benign prostate hyperplasia (BPH).
- BPH benign prostate hyperplasia
- Benign prostate hyperplasia is a condition which affects well over 50% of the male population over 50 years of age.
- the treatment of BPH is a matter of great medical and commercial importance. On a worldwide basis, upwards of four billion dollars are spent annually in the treatment of this condition.
- catheters which are placed in the external opening of the urethra and into at least the obstructed portions of the urethra which allow the passage of urine from the bladder by way of the catheter lumen.
- These urinary catheters typically employ a positioning or retention balloon at the distal tip which, at the bladder neck, when inflated, prevents the expulsion of the catheter from the body.
- positioning balloon catheters are those known in the art as Foley catheters.
- This patent discloses an expansion catheter having a rapidly expandable tubular stent associated therewith, which is adapted for transurethral insertion via the external opening of the urethra and for placement within an obstructed region of the urethral lumen caused by a hypertrophied prostate gland. Removal of the expansion catheter leaving in place an expanded tubular stent may result in long term patency of the urethral lumen.
- the stent is also adapted to be removable from the urethra, the intent of the device is to establish a long-term implant.
- U.S. Patent 5,163,952 to Froix there is disclosed an expandable stent for use in a lumen defined by a wall of a vessel, which illustratively is defined as an arterial vessel in the heart.
- the polymeric stent has a built-in elastic predetermined diameter and a memory of a diameter greater than the predetermined diameter which is assumed upon activation of a thermal activation point by the adsorption of heat by the plastic, adsorption of liquid by the plastic, or a change in the pH of the liquid surrounding the plastic.
- U.S. Patent 5,084,060 there is provided an apparatus for applying fluidic pressure to the inside of a body vessel during selected intervals to incrementally enlarge the lumen of the vessel.
- Patent 4,660,560 to Klein there is disclosed a method for treating obstructive prostatism which comprises measuring the distance between the bladder neck and the veru montanum, inserting a dilating catheter into the urethra, and positioning the same, such as through the use of a positioning balloon which can be located in the bladder neck.
- WO 95/03848 discloses a method and device for slowly dilating the urethra utilizing a hollow member permitting urination therethrough from the bladder, and hydrophilic means associated therewith which are capable of absorbing water and slowly swelling, thereby dilating the urethra.
- the present invention relates to a device for slowly dilating an obstructed portion of the urethra, which comprises a urinary catheter, for insertion in the prostatic urethra, having a proximal portion and a distal portion.
- dilation means Disposed on the catheter between the proximal and distal portion is dilation means having a length of at least that of the obstructed portion of the urethra. Also provided is pressure responsive means which is capable of sequentially contracting under pressure, the pressure responsive means and the dilation means being in fluid communication with each other. When the pressure responsive means contracts under pressure, fluid flows therefrom into the dilation means at a predetermined rate to cause the dilation means to expand gradually (and controllably) in a radially outwardly direction, and with sufficient impacting force to cause the obstructed portion of the urethra to dilate to a desired diameter and configuration.
- the present invention provides a method for slowly dilating an obstructed portion of a urethra by the sequential transfer of fluid from pressure responsive means, which is capable of expanding and contracting, into dilation means which are thereby radially expanded, the expanded dilation means thereby impacting upon the obstructed portion of the urethra with sufficient, and preferably constant, force to cause the latter to gradually dilate to a desired diameter and configuration.
- the present invention also provides a method for treating benign prostatic hyperplasia which comprises the aforesaid method of dilating an obstructed portion of the urethra thereby relieving the obstruction caused by the hypertrophy of the prostate gland.
- a single inflation/deflation lumen is provided to effect initially the full inflation of the pressure responsive means, and (less than complete) inflation of the dilation means.
- the extent of dilation is thereby not adequate, or only partially adequate, to dilate the urethra in the manner desired.
- the subsequent contraction (and at least partial deflation) of the pressure responsive means results in the necessary full inflation of the dilation means thereby resulting in the dilation of the urethra.
- the pressure responsive means is disposed at or near the distal portion of the catheter and is capable of initially being inflated to a maximum extent due to the onset of fluid, from a single inflation lumen or conduit.
- This lumen can also act to transfer fluid to the dilation means upon contraction of the pressure responsive means.
- the flow of liquid from the pressure responsive means when it is in a contracting mode, be effected through a separately disposed conduit or lumen, as hereinafter described.
- the flow of fluid proceeds at a controlled rate, typically through fluid resistor means, which can be of the kind known in the art.
- the slow or gradual dilation of the urethra has the significant advantage of alleviating or lessening the discomfort felt by the patient which is the concomitant effect when rapid dilation of the urethra occurs, i.e. on the order of 10 minutes or less, as is the case with the usual dilation currently effected by most prior art devices.
- an expansion rate of between about 5 French and about 20 French over a 24 hour period is desirable to effect the dilation of at least the obstructed portion of the urethra to a maximum or desired diameter and configuration.
- the dilation means, disposed on the catheter is usually in the form of a dilation balloon having an outer surface capable of expanding radially outwardly for a period of at least about 30 minutes.
- the length of the dilation balloon on the catheter should correspond to the length of at least that of the obstructed portion of the urethra.
- the inflation balloon can be elastic without a defined limit of intrinsic expansion or can also have a defined shape and an intrinsic limit to expansion.
- the pressure responsive means can optionally be in the form of an expandable and contractible balloon which can also act as a positioning balloon when located in the area of the bladder neck of the body.
- a separate positioning balloon can also be disposed as part of the device of this invention as, for example, in the area of the bulbous urethra.
- other suitable means can be employed to fix or position the device of this invention.
- Another aspect of this invention is the fact that it can be adapted to remain in the urethra for extended periods of time before removal.
- Such an extended presence can be on the order of at least about 5 days to about 30 days, the latter being a desirable upper limit because of clinical efficacy and patient comfort.
- the dilated urethral configuration will tend to remain in such configuration for an extended period of time, even after the device is removed. Up to 12-24 months or more is likely before obstruction of the prostatic urethra will occur again. This is a highly desirable result of this aspect of the invention.
- the device of this invention can be in the form of a unitary catheter, it is also contemplated that the device can comprise a stent having the aforesaid dilation means and pressure responsive means thereon, which can remain in the dilated urethra for the desired time, and a removable section for inserting the stent, which can include a filling tube for effecting the initial flow of fluid into the stent.
- Any suitable attachable means can be provided for removing a unitary catheter after deflation of both the dilation means and the pressure responsive means. If the catheter comprises a stent and a removable section, the latter is by its nature removable by the simple act of withdrawing the section after it is detached from the stent.
- the means for removing the stent from the dilated urethra can be accomplished by any means known in the art, such as the use of clamps or pull strings.
- FIG. 1 is a simplified sectional view of the relevant anatomy of a male body, showing an obstructed urethra, an enlarged prostate gland, a bladder, and a schematic unexpended dilation device of the subject invention, as hereinafter described, which is positioned just before insertion into the obstructed portion of the prostatic urethra.
- Fig. 2 is a sectional view of a portion of Fig. 1 depicting a portion of the dilation device, in a non-expanded state, implanted within the obstructed portion of the urethra. Pressure responsive means is shown distally disposed inside the bladder.
- Fig. 3 is a sectional view of the device shown in Fig. 2, in an expanded state, and indicating the concomitant dilation of the prostatic urethra, wherein the pressure responsive means, though partially deflated, is acting as a positioning balloon.
- Fig. 4 is a schematic view of a dilation device of this invention, wherein the pressure responsive means and dilation balloon are in fluid communication through a single lumen, the device further comprising a stent portion and a detachable inserter.
- Fig. 5 is a schematic view of a dilation device of this invention wherein the pressure responsive means also serves as a positioning balloon, and a separate lumen provides further fluid communication between the dilation balloon and the pressure responsive/positioning balloon.
- a urethra 10 having an obstructed portion 12 about which is depicted an enlarged hypertrophied prostate gland 14, which inferentially is pressing inwardly on the obstructed portion 12. Also shown is a bladder 16 having a neck 18 depending therefrom, and at the other end of the urethra is a penis 20.
- Fig. 2 there is shown a simplified sectional view of the portion 24 when placed in the obstructed portion of the urethra.
- the portion 24 is depicted in an unexpended mode.
- Extending through the portion 24 is a draining lumen 28 having a bladder drainage port 30 in the distal portion of the device which communicates with the drainage lumen, for permitting the flow of urine therethrough, i.e., from the bladder through the urethra and out of the penis.
- Protruding portion 26 can be attached to suitable means for insertion.
- the lumen 28 acts as a conduit having a diameter sufficient to permit urine to flow therethrough.
- a pressure responsive inflatable source 32 is shown disposed in the distal portion of the portion 24 which, when secured in the body, would usually be in the area of the bladder neck.
- Inflatable means 34 which is preferably in the form of a dilation balloon, is disposed along the outer surface of the portion 24 and has a length at least equal to that of the obstructed portion of the urethra.
- the portion 24 of the device of the subject invention should be of a minimum diameter, including the pressure responsive means and dilation balloon, which would allow the device 22 to be inserted into the penis and then into the obstructed portion of the urethra with a minimum of discomfort.
- the dilation balloon should be a material capable of expanding outwardly and radically so as to impact upon the obstructed urethra, in order to expand and dilate the obstructed portion 12 of the urethra 10 to a predetermined diameter and (dilated) configuration.
- the dilation balloon 34 of the dilation device of this invention is shown in an expanded, inflated state with outer surface 36 impacting on the obstructed portion of the urethra.
- the portion 12 of the urethra, formerly obstructed by the hyperplasia of the prostate gland, is now shown in a dilated configuration.
- the pressure responsive means or pressure source 32 is initially completely inflated but in the final operable mode of this embodiment wherein the urethra is inflated, the pressure responsive means 32 is only partially inflated; however, it remains sufficiently inflated so that, in this embodiment, it also acts as a positioning balloon, located at the bladder neck.
- a pressure source 32 is disposed in the distal portion of the device, on the portion 24, which is in the form of a stent, and a dilation envelope 34, which is preferably a balloon such as is normally used in this art, is disposed proximal to but not abutting with the pressure source. Downstream from the dilation balloon, but in this embodiment still a part of the stent, is a location or positioning balloon 38.
- the pressure source 32 is adapted to be disposed in the bladder while the positioning balloon 38 is adapted to be disposed in the area of the bulbous urethra.
- the pressure source may act as an additional positioning means, which will aid in retaining the device within the urethra.
- the dilation balloon is of a length of at least that of the obstructed portion of the urethra.
- an attaching inserter member 40 which preferably can be detachable, leaving the stent in the urethra.
- the inserter and stent can remain undetached, i.e., the device thereby functioning as a catheter.
- Means 42 illustratively in the form a needle and septum, for attaching or detaching the catheter, can also be provided.
- draining lumen 28 extends through the device 22.
- Location balloon 38, dilation balloon 34 and pressure source 32 are also in fluid communication with each other through lumen 44 which extends through device 22.
- Port 39 permits the flow of fluid into location balloon 38.
- Ports 35 and 33 permit the flow of fluid into the dilation balloon 34 and pressure source 32 respectively.
- the passage of fluid from outside the penis through lumen 44 is controlled so that the positioning balloon 38 and the pressure source 32 are fully inflated, but in the context of this invention, the dilation balloon 34 is initially only partially inflated, i.e., to an extent less than that needed to impact with sufficient force to dilate the obstructed portion of the urethra.
- pressure source 32 contracts due to the pressure differential between that of the pressure source and the pressure exerted on the dilation balloon by the hypertrophied prostate
- fluid will flow at a predetermined rate from the pressure source into the dilation balloon so as to slowly and gradually expand the latter to the extent necessary for it to impact with sufficient force to dilate the obstructed portion of the urethra.
- the rate of this flow can also be determined by the geometry and elastic modulus of the pressure balloon, which will contrast to the resistance of the prostate tissue surrounding the dilation balloon.
- Fig. 5 there is shown an embodiment of this invention in which the pressure responsive balloon 32 also serves as a positioning balloon which would be adapted to be located in the bladder neck. Also shown in this figure is the single lumen 44 which is in fluid communication with the pressure responsive balloon 32 and serves to initially fully inflate the pressure responsive balloon.
- separate lumen 46 provides for the passage of fluid from the contracting pressure balloon 32 into the dilation balloon 34, to effect the desired expansion of the latter.
- Lumen 46 continues to the end of the stent.
- a fluid resistor 48 (which can be of a type well known in the art) which acts to control the rate of passage of fluid from pressure source 32 to dilation balloon 0 14
- Port 50 allows fluid to enter the dilation balloon from lumen 46.
- a drainage plug 52 can be utilized. A suitable plug is described in U.S. patent 5,112,306.
- the pressure responsive means cen optionally be disposed outside of the body in the form of, for example, a syringe pump or pump bulb.
- fluid can be transferred into the diletion means by epplying suitable pressure in carefully monitored amounts to thereby slowly dilate the diletion means.
- the diemeter of the unexpended devices of this invention should be on the order of between about 20 and about 26 French. Generally speaking, diameters of less than about 20 French will not permit adequate urination in combination with desired dilation, while the insertion into the meatus of the penis prior to insertion into an obstructed prostatic urethra of an unexpanded device having a diameter of more than about 26 French will usually be too painful for ⁇ petient. It thus follows thet the diemeter of the lumens of the devices of this invention should be fixed within the tolerable limits of the diametral range of the unexpanded device, preferably on or ebout 20 French.
- the greduel, slow diletion of the diletion balloon should occur over e period of et least 30 minutes, and preferably over a much longer period, a dilation which occurs et e rate of about 5 French per 20 hour period being particulerly desirable.
- a dilation which occurs et e rate of about 5 French per 20 hour period being particulerly desirable.
- the slow dilation could take as long es 9 or 10 deys. A long expansion period may also result in a longer patency for the resulting dilation.
- the device of the subject invention is adepted to remain in the urethr ⁇ for periods on the order of seven days to 30 days, the latter being ⁇ pr ⁇ cticel upper limit for retention in the urethre for biocompetible reesons, such es possible urinary tract infection, increesed inflammation or bacterially besed prostatitis.
- the dilated urethra will tend to remain in its dilated configuration for a period on the order of about 12 to about 24 months, or longer, i.e., the patency of the urethral lumen or canal will tend to remain in its dilated state.
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP08526731A JP3133074B2 (en) | 1995-03-07 | 1996-02-26 | Device for slow dilation of the urethra |
CA002213474A CA2213474C (en) | 1995-03-07 | 1996-02-26 | Slowly dilating device for the urethra |
DE69622158T DE69622158T2 (en) | 1995-03-07 | 1996-02-26 | DEVICE FOR SLOW DILATION OF THE URETHES |
EP96901938A EP0813434B1 (en) | 1995-03-07 | 1996-02-26 | Slowly dilating device for the urethra |
AU46320/96A AU709615B2 (en) | 1995-03-07 | 1996-02-26 | Slowly dilating device for the urethra |
MXPA/A/1997/006720A MXPA97006720A (en) | 1995-03-07 | 1997-09-04 | Device to slowly dilate the ure |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/399,789 US5588965A (en) | 1995-03-07 | 1995-03-07 | Device for slowly dilating the prostatic urethra |
US08/399,789 | 1995-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996027406A1 true WO1996027406A1 (en) | 1996-09-12 |
Family
ID=23580974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1996/000143 WO1996027406A1 (en) | 1995-03-07 | 1996-02-26 | Slowly dilating device for the urethra |
Country Status (7)
Country | Link |
---|---|
US (1) | US5588965A (en) |
EP (1) | EP0813434B1 (en) |
JP (1) | JP3133074B2 (en) |
AU (1) | AU709615B2 (en) |
CA (1) | CA2213474C (en) |
DE (1) | DE69622158T2 (en) |
WO (1) | WO1996027406A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997036630A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Urinary catheter |
WO1998050100A1 (en) * | 1997-05-02 | 1998-11-12 | Children's Medical Center Corporation | Systems and methods for promoting tissue growth |
AU736024B2 (en) * | 1996-07-02 | 2001-07-26 | Urocath Corporation | Anchoring system and method for indwelling urethral catheter |
US6287275B1 (en) | 1994-10-20 | 2001-09-11 | Children's Medical Center Corporation | Systems and methods for promoting tissue growth |
EP2300092A1 (en) * | 2008-06-17 | 2011-03-30 | Antoine Trubiano | Catheter device for the control of liquid discharge from the urinary bladder by a user person |
US9764119B2 (en) | 2014-09-30 | 2017-09-19 | Terumo Kabushiki Kaisha | Urethral stricture treatment apparatus and urethral stricture treatment method |
US10765838B2 (en) | 2015-02-25 | 2020-09-08 | Terumo Kabushiki Kaisha | Medical device, medical device assembly, balloon device, and treatment method for treating urethral stricture |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549559A (en) | 1990-03-22 | 1996-08-27 | Argomed Ltd. | Thermal treatment apparatus |
FR2722413B1 (en) * | 1994-07-13 | 1997-02-07 | Marian Devonec | THERAPEUTIC IMPLANT INTENDED FOR THE SELECTIVE CYTOREDUCTIVE TREATMENT OF LIGHT OR NATURAL PATH OBSTRUCTION OF A HUMAN OR ANIMAL BODY |
US6052612A (en) * | 1995-06-07 | 2000-04-18 | Desai; Jawahar M. | Catheter for media injection |
US6135981A (en) * | 1997-10-22 | 2000-10-24 | Dyke; Charles C. | Protective aortic occlusion catheter |
US6893430B2 (en) | 1998-02-04 | 2005-05-17 | Wit Ip Corporation | Urethral catheter and guide |
US6517515B1 (en) * | 1998-03-04 | 2003-02-11 | Scimed Life Systems, Inc. | Catheter having variable size guide wire lumen |
US6021781A (en) * | 1998-03-18 | 2000-02-08 | Medworks Corporation | Intraurethral pressure monitoring assembly and method of treating incontinence using same |
US6113609A (en) * | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
AU4073099A (en) * | 1998-07-21 | 2000-02-14 | Heartport, Inc. | Multi-lumen catheters and methods of use and manufacture |
US5954694A (en) | 1998-08-07 | 1999-09-21 | Embol-X, Inc. | Nested tubing sections and methods for making same |
US6669711B1 (en) | 1998-08-17 | 2003-12-30 | Koken Co. Ltd. | Operation balloon |
US6494879B2 (en) | 1998-10-15 | 2002-12-17 | Scimed Life Systems, Inc. | Treating urinary retention |
US6299599B1 (en) * | 1999-02-19 | 2001-10-09 | Alsius Corporation | Dual balloon central venous line catheter temperature control system |
US6048350A (en) * | 1999-06-14 | 2000-04-11 | Scimed Life Systems, Inc. | Segmented balloon delivery system |
US6716252B2 (en) | 2000-06-30 | 2004-04-06 | Wit Ip Corporation | Prostatic stent with localized tissue engaging anchoring means and methods for inhibiting obstruction of the prostatic urethra |
US6695787B2 (en) * | 2000-08-25 | 2004-02-24 | Neoseed Technology Llc. | Prostate visualization device and methods of use |
CN100528074C (en) * | 2000-10-23 | 2009-08-19 | 伊西康公司 | Apparatus and method for the measurement and assessment of sling-tension for treatment of female urinary incontinence |
US6758857B2 (en) * | 2000-11-13 | 2004-07-06 | Acmi Corporation | Treatment catheters with thermally insulated regions |
US6981964B2 (en) | 2001-05-22 | 2006-01-03 | Boston Scientific Scimed, Inc. | Draining bodily fluids with a stent |
US6790223B2 (en) | 2001-09-21 | 2004-09-14 | Scimed Life Systems, Inc. | Delivering a uretheral stent |
US6733536B1 (en) | 2002-10-22 | 2004-05-11 | Scimed Life Systems | Male urethral stent device |
US7655021B2 (en) * | 2003-03-10 | 2010-02-02 | Boston Scientific Scimed, Inc. | Dilator with expandable member |
US7651529B2 (en) | 2003-05-09 | 2010-01-26 | Boston Scientific Scimed, Inc. | Stricture retractor |
IL164563A0 (en) * | 2004-10-13 | 2005-12-18 | Protech Medical Technologies L | Prostate treatment stent |
US7744574B2 (en) | 2004-12-16 | 2010-06-29 | Boston Scientific Scimed, Inc. | Catheter tip to reduce wire lock |
US8277466B2 (en) * | 2006-11-14 | 2012-10-02 | Ams Research Corporation | Anastomosis device and method |
WO2008086195A1 (en) * | 2007-01-05 | 2008-07-17 | Kim Daniel H | Apparatus and method for prostatic tissue removal |
US8287602B2 (en) * | 2007-12-12 | 2012-10-16 | Boston Scientific Scimed, Inc. | Urinary stent |
US8192352B2 (en) * | 2009-12-15 | 2012-06-05 | Coloplast A/S | Instrument configured to prepare a penis for implantation of a penile prosthetic |
US8002692B2 (en) * | 2009-12-16 | 2011-08-23 | Coloplast A/S | Method of preparing a penis for implantation of a penile prosthetic |
US8491621B2 (en) * | 2010-01-04 | 2013-07-23 | Coloplast A/S | Instrument with expandable member configured to prepare a penis for implantation of a penile prosthetic |
US8403825B2 (en) * | 2010-01-05 | 2013-03-26 | Coloplast A/S | Instrument with expandable member configured to prepare a penis for implantation of a penile prosthetic |
US10137279B2 (en) | 2012-11-29 | 2018-11-27 | William Beaumont Hospital | Catheter guide and method for utilizing the same |
US9549729B2 (en) | 2015-02-06 | 2017-01-24 | Coloplast A/S | System for implanting a penile prosthetic includes a suture and a needle inserted into a tool |
US9724502B2 (en) | 2015-07-10 | 2017-08-08 | Coloplast A/S | Dilator and method for penile prosthetic implantation |
DE102015008784A1 (en) * | 2015-07-13 | 2017-01-19 | Jotec Gmbh | Balloon Catheter |
US10201689B1 (en) | 2017-08-07 | 2019-02-12 | Advanced Dilation Strategies, LLC | Urethral balloon dilator catheter |
US10806476B2 (en) | 2017-11-12 | 2020-10-20 | David Awrey Randall | Anterior—posterior inflatable nosebleed packing |
CN110180075B (en) * | 2019-05-26 | 2022-02-11 | 靖璟 | Prostate air sac dilating catheter with protective end |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4546756A (en) * | 1981-12-14 | 1985-10-15 | G&G Solar, Inc. | Tracking system |
WO1986005990A1 (en) * | 1985-04-09 | 1986-10-23 | Harvey Wolinsky | Method for the prevention of restenosis |
US4932938A (en) * | 1989-05-05 | 1990-06-12 | Medical Engineering Corporation | Urethral indwelling catheter with incontinence control |
US5084016A (en) * | 1989-09-05 | 1992-01-28 | Freeman Andrew B | Epidural catheter apparatus with an inflation fitting |
US5135494A (en) * | 1988-08-01 | 1992-08-04 | Target Therapeutics | Valved catheter device and method |
US5167627A (en) * | 1990-09-13 | 1992-12-01 | Abbott Laboratories | Stoma creator gastrostomy device and method for placement of a feeding tube |
EP0552934A2 (en) * | 1992-01-21 | 1993-07-28 | Med Institute, Inc. | Transurethral ablation catheter |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2799273A (en) * | 1955-03-22 | 1957-07-16 | Vincent J Oddo | Haemostatic catheter |
WO1980000302A1 (en) * | 1978-08-02 | 1980-03-06 | S Hakky | Improvements in surgical implants |
GB2035350B (en) * | 1978-11-08 | 1983-04-27 | Taylor D | Biocompatible surgical devices |
SE424045B (en) * | 1979-01-12 | 1982-06-28 | Tesi Ab | CATHETER |
DE3235974A1 (en) * | 1981-11-24 | 1983-06-01 | Volkmar Dipl.-Ing. Merkel (FH), 8520 Erlangen | DEVICE FOR REMOVAL OR FOR THE EXPANSION OF CONSTRAINTS IN BODY LIQUID LEADING VESSELS |
US4636195A (en) * | 1982-04-02 | 1987-01-13 | Harvey Wolinsky | Method and apparatus for removing arterial constriction |
SE445884B (en) * | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
US4480642A (en) * | 1982-07-26 | 1984-11-06 | Health Products Research, Inc. | Dilation device for the cervix |
GB2139898B (en) * | 1983-05-09 | 1986-08-06 | Donald James Highgate | Deformable polymeric compositions |
ES8705239A1 (en) * | 1984-12-05 | 1987-05-01 | Medinvent Sa | A device for implantation and a method of implantation in a vessel using such device. |
US4660560A (en) * | 1985-05-30 | 1987-04-28 | The Beth Israel Hospital Association | Method for treating obstructive prostatism |
US5007898A (en) * | 1988-06-02 | 1991-04-16 | Advanced Surgical Intervention, Inc. | Balloon dilatation catheter |
US5527336A (en) * | 1986-12-09 | 1996-06-18 | Boston Scientific Corporation | Flow obstruction treatment method |
US4762128A (en) * | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
DK163713C (en) * | 1987-09-02 | 1992-09-07 | Ole Gyring Nieben | DEVICE FOR THE POSITION OF A PARTICULAR CATHETTE IN A BODY |
US4886062A (en) * | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4994047A (en) * | 1988-05-06 | 1991-02-19 | Menlo Care, Inc. | Multi-layer cannula structure |
US4932958A (en) * | 1988-05-10 | 1990-06-12 | American Medical Systems, Inc. | Prostate balloon dilator |
US4932956A (en) * | 1988-05-10 | 1990-06-12 | American Medical Systems, Inc. | Prostate balloon dilator |
IT1225673B (en) * | 1988-07-22 | 1990-11-22 | Luigi Bozzo | DESTRUCTOR DEVICE FOR USE IN THE URINARY OBSTRUCTIVE PATHOLOGY OF THE MALE AND INSTRUCTOR-EXTRACTOR INSTRUMENT OF THE DEVICE ITSELF |
US4950227A (en) * | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
US5084060A (en) * | 1989-02-15 | 1992-01-28 | Freund Precision, Inc. | Apparatus for enlarging a vessel or clearing obstructive tissue from a vessel according to vessel compliance |
US5192289A (en) * | 1989-03-09 | 1993-03-09 | Avatar Design And Development, Inc. | Anastomosis stent and stent selection system |
US4955859A (en) * | 1989-07-07 | 1990-09-11 | C. R. Bard, Inc. | High-friction prostatic stent |
US4973301A (en) * | 1989-07-11 | 1990-11-27 | Israel Nissenkorn | Catheter and method of using same |
US5104377A (en) * | 1989-08-10 | 1992-04-14 | C. R. Bard, Inc. | Uterine access device with automatic cervical adjustment |
US5002558A (en) * | 1989-08-23 | 1991-03-26 | The Beth Israel Hospital Association | Adjustable urethral catheter and method for treating obstructive prostatism |
US5152776A (en) * | 1990-04-03 | 1992-10-06 | Cordis Corporation | Balloon inflation device |
FR2660543B1 (en) * | 1990-04-06 | 1998-02-13 | Technomed Int Sa | METHOD FOR AUTOMATICALLY MEASURING THE VOLUME OF A TUMOR, IN PARTICULAR A PROSTATE TUMOR, MEASURING DEVICE, METHOD AND APPARATUS COMPRISING THE SAME. |
US5071429A (en) * | 1990-08-24 | 1991-12-10 | Medical Engineering Corporation | Method for inserting a balloon catheter through an endoscope |
US5258020A (en) * | 1990-09-14 | 1993-11-02 | Michael Froix | Method of using expandable polymeric stent with memory |
US5163952A (en) * | 1990-09-14 | 1992-11-17 | Michael Froix | Expandable polymeric stent with memory and delivery apparatus and method |
US5188596A (en) * | 1990-09-27 | 1993-02-23 | Mentor Corporation | Transparent prostate dilation balloon and scope |
US5209725A (en) * | 1991-04-11 | 1993-05-11 | Roth Robert A | Prostatic urethra dilatation catheter system and method |
US5269802A (en) * | 1991-09-10 | 1993-12-14 | Garber Bruce B | Prostatic stent |
JPH0576603A (en) * | 1991-09-20 | 1993-03-30 | Olympus Optical Co Ltd | Organic duct expander |
JPH0576602A (en) * | 1991-09-20 | 1993-03-30 | Olympus Optical Co Ltd | Organic duct expander |
US5282860A (en) * | 1991-10-16 | 1994-02-01 | Olympus Optical Co., Ltd. | Stent tube for medical use |
US5167614A (en) * | 1991-10-29 | 1992-12-01 | Medical Engineering Corporation | Prostatic stent |
US5224953A (en) * | 1992-05-01 | 1993-07-06 | The Beth Israel Hospital Association | Method for treatment of obstructive portions of urinary passageways |
US5499994A (en) * | 1993-07-30 | 1996-03-19 | American Medical Systems, Inc. | Dilation device for the urethra |
US5419763B1 (en) * | 1994-01-04 | 1997-07-15 | Cor Trak Medical Inc | Prostatic drug-delivery catheter |
-
1995
- 1995-03-07 US US08/399,789 patent/US5588965A/en not_active Expired - Lifetime
-
1996
- 1996-02-26 WO PCT/IB1996/000143 patent/WO1996027406A1/en active IP Right Grant
- 1996-02-26 AU AU46320/96A patent/AU709615B2/en not_active Ceased
- 1996-02-26 CA CA002213474A patent/CA2213474C/en not_active Expired - Fee Related
- 1996-02-26 JP JP08526731A patent/JP3133074B2/en not_active Expired - Fee Related
- 1996-02-26 DE DE69622158T patent/DE69622158T2/en not_active Expired - Fee Related
- 1996-02-26 EP EP96901938A patent/EP0813434B1/en not_active Expired - Lifetime
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4546756A (en) * | 1981-12-14 | 1985-10-15 | G&G Solar, Inc. | Tracking system |
WO1986005990A1 (en) * | 1985-04-09 | 1986-10-23 | Harvey Wolinsky | Method for the prevention of restenosis |
US5135494A (en) * | 1988-08-01 | 1992-08-04 | Target Therapeutics | Valved catheter device and method |
US4932938A (en) * | 1989-05-05 | 1990-06-12 | Medical Engineering Corporation | Urethral indwelling catheter with incontinence control |
US5084016A (en) * | 1989-09-05 | 1992-01-28 | Freeman Andrew B | Epidural catheter apparatus with an inflation fitting |
US5167627A (en) * | 1990-09-13 | 1992-12-01 | Abbott Laboratories | Stoma creator gastrostomy device and method for placement of a feeding tube |
EP0552934A2 (en) * | 1992-01-21 | 1993-07-28 | Med Institute, Inc. | Transurethral ablation catheter |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048330A (en) * | 1994-10-20 | 2000-04-11 | Children's Medical Center Corporation | Systems and methods for promoting tissue growth |
US6287275B1 (en) | 1994-10-20 | 2001-09-11 | Children's Medical Center Corporation | Systems and methods for promoting tissue growth |
US6432081B1 (en) | 1994-10-20 | 2002-08-13 | Children's Medical Center Corporation | Systems and methods for promoting tissue growth |
WO1997036630A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Urinary catheter |
AU736024B2 (en) * | 1996-07-02 | 2001-07-26 | Urocath Corporation | Anchoring system and method for indwelling urethral catheter |
WO1998050100A1 (en) * | 1997-05-02 | 1998-11-12 | Children's Medical Center Corporation | Systems and methods for promoting tissue growth |
EP2300092A1 (en) * | 2008-06-17 | 2011-03-30 | Antoine Trubiano | Catheter device for the control of liquid discharge from the urinary bladder by a user person |
EP2300092A4 (en) * | 2008-06-17 | 2011-07-06 | Antoine Trubiano | Catheter device for the control of liquid discharge from the urinary bladder by a user person |
US9764119B2 (en) | 2014-09-30 | 2017-09-19 | Terumo Kabushiki Kaisha | Urethral stricture treatment apparatus and urethral stricture treatment method |
US10765838B2 (en) | 2015-02-25 | 2020-09-08 | Terumo Kabushiki Kaisha | Medical device, medical device assembly, balloon device, and treatment method for treating urethral stricture |
Also Published As
Publication number | Publication date |
---|---|
EP0813434B1 (en) | 2002-07-03 |
DE69622158T2 (en) | 2003-03-06 |
MX9706720A (en) | 1997-11-29 |
US5588965A (en) | 1996-12-31 |
AU4632096A (en) | 1996-09-23 |
EP0813434A1 (en) | 1997-12-29 |
CA2213474C (en) | 2002-03-12 |
CA2213474A1 (en) | 1996-09-12 |
JP3133074B2 (en) | 2001-02-05 |
AU709615B2 (en) | 1999-09-02 |
JPH10506038A (en) | 1998-06-16 |
DE69622158D1 (en) | 2002-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5588965A (en) | Device for slowly dilating the prostatic urethra | |
US7766899B2 (en) | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots | |
US5499994A (en) | Dilation device for the urethra | |
US5322501A (en) | Continent urethral stent for treating and preventing urethral stricture after surgery | |
US4893623A (en) | Method and apparatus for treating hypertrophy of the prostate gland | |
US4762128A (en) | Method and apparatus for treating hypertrophy of the prostate gland | |
EP0417189B1 (en) | Balloon dilation catheter | |
JP2872122B2 (en) | Separable catheter | |
US5916195A (en) | Internal catheter | |
US6893430B2 (en) | Urethral catheter and guide | |
JP4427546B2 (en) | Partial length indwelling prostate catheter with inflation tube anchor, occlusion resistance and removal function | |
WO2008132735A1 (en) | A urethral implant and method | |
US20080033570A1 (en) | Prostatic stent placement device | |
MXPA97006720A (en) | Device to slowly dilate the ure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA DE JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2213474 Country of ref document: CA Ref country code: CA Ref document number: 2213474 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996901938 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1997/006720 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 1996901938 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996901938 Country of ref document: EP |